Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Vectorite Biomedical, Inc. (4170) Financial Statements

Vectorite Biomedical, Inc. Financial Overview

Vectorite Biomedical, Inc.'s market cap is currently NT$481.49M. The company's EPS TTM is NT$2.70; its P/E ratio is 4.07; Vectorite Biomedical, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 61.41MNT$ 57.77MNT$ 55.85MNT$ 42.91MNT$ 28.77M
Gross ProfitNT$ 21.68MNT$ 16.97MNT$ 16.42MNT$ 707.00KNT$ -2.47M
Operating IncomeNT$ -21.91MNT$ -25.97MNT$ -16.13MNT$ 30.54MNT$ -42.39M
EBITDANT$ -13.77MNT$ -17.21MNT$ -6.97MNT$ -21.68MNT$ -25.94M
Net IncomeNT$ 96.14MNT$ -40.05MNT$ -6.60MNT$ -26.41MNT$ 8.36M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 170.61MNT$ 184.90MNT$ 203.67MNT$ 213.52MNT$ 239.38M
Total AssetsNT$ 509.56MNT$ 412.78MNT$ 452.10MNT$ 465.82MNT$ 492.64M
Total DebtNT$ 385.00KNT$ 0.00NT$ 0.00NT$ 0.00NT$ 0.00
Net DebtNT$ -25.32MNT$ -30.60MNT$ -25.32MNT$ -27.87MNT$ -39.20M
Total LiabilitiesNT$ 24.48MNT$ 23.20MNT$ 21.25MNT$ 24.49MNT$ 25.71M
Stockholders' EquityNT$ 484.71MNT$ 389.16MNT$ 430.44MNT$ 440.90MNT$ 466.51M
Cash Flow
Free Cash FlowNT$ -9.78MNT$ -14.35MNT$ -3.46MNT$ 13.81MNT$ -67.59M
Operating Cash FlowNT$ -5.79MNT$ -11.51MNT$ 1.30MNT$ 14.70MNT$ -65.79M
Investing Cash FlowNT$ 1.34MNT$ 16.36MNT$ -3.82MNT$ -26.34MNT$ -41.67M
Financing Cash FlowNT$ -344.00KNT$ 200.00KNT$ 0.00NT$ 0.00NT$ 118.08M

Currency in TWD

Vectorite Biomedical, Inc. Earnings and Revenue History

-120M0120M240M-400 %-200 %0 %200 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Vectorite Biomedical, Inc. Liabilities to Assets

0250M500M750M0 %15 %30 %45 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Vectorite Biomedical, Inc. Cash Flow

-200M-150M-100M-50M050M100M150M201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Vectorite Biomedical, Inc. Forecast EPS vs Actual EPS

Earnings >